NLRP3 and Insulin resistance: By interfering with NLRP3-mediated signaling at various stages—priming, activation, oligomerization, or downstream cytokine release—these compounds offer promising avenues for mitigating insulin resistance and inflammation in cardio-metabolic diseases.